EPI Engineering, founded in 2006 as a design and consulting firm, has provided professional facility engineering services in the biotechnology industry for many years. By collaborating with selected local architectural design institutes, we are expanding our business to offer excellent design services in North America and emerging markets. We facilitate a single point of contact with our project owners while ensuring that the modern GMP biopharmaceutical manufacturing facility designs incorporate local codes and construction feasibility.

The core competence of EPI lies in its Subject Matter Experts (SMEs), who are highly qualified senior engineers with professional abilities derived from profound theoretical knowledge and extensive global experience.

The biopharmaceutical plants we have designed include:

· CHO, BHK, and Per.C6 mammalian cell culture for expressing monoclonal antibodies, fusion proteins, human vaccines, animal vaccines, hormones, etc.

· E. coli and yeast intracellular system-based VLP vaccines, rHSA, insulin, etc.